Modulation of urokinase-type plasminogen activator and metalloproteinase activities in cultured mouse mammary-carcinoma cells: Enhancement by paclitaxel and inhibition by nocodazole

International Journal of Cancer

Volumn 83, Issue 2, 1999, Pages 242-246

  Alonso, Daniel F ^a   Farina, Hernán G ^a   Arregui, Carlos ^b   Aon, Miguel A ^b   Gomez, Daniel E ^a  

^a UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

^b Technol Inst of Chascomùs   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

NOCODAZOLE; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CYTOPATHOGENIC EFFECT; DEPOLYMERIZATION; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN CELL; IMMUNOBLOTTING; MICROTUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; COLLAGENASES; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; MICROTUBULES; NOCODAZOLE; PACLITAXEL; SECRETORY RATE; TUBULIN; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0032870178     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991008)83:2<242::AID-IJC16>3.0.CO;2-8     Document Type: Article

References (28)

1. AGUIRRE GHISO, J.A., FARIAS, E.F., ALONSO, D.F., ARREGUI, C. and BAL DE KIER JOFFE, E., A phospholipase D and protein kinase C inhibitor blocks the spreading of murine mammary adenocarcinoma cells altering F-actin and β1-integrin point contact distribution. Int. J. Cancer, 71, 881-890 (1997).
2. ALONSO, D.F., FARIAS, E.F., LADEDA, V., DAVEL, L., PURICELLI, L. and BAL DE KIER JOFFE, E., Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model. Breast Cancer Res. Treat., 40, 209-223 (1996a).
3. ALONSO, D.F., FARIAS, E.F., URTREGER, A., LADEDA, V., VIDAL, M.C.C. and BAL DE KIER JOFFE, E., Characterization of F3II, a sarcomatoid mammary carcinoma cell line originated from a clonal subpopulation of a mouse adenocarcinoma. J. surg. Oncol., 62, 288-297 (1996b).
4. ALONSO, D.F., SKILTON, G., FARINA, H.R.G., DE LORENZO, M.S. and GOMEZ, D.E., Modulation of growth and urokinase secretion by vasopressin and closely related nonapeptides in metastatic mouse mammary tumor cells. Int. J. Oncol., 10, 375-379 (1997).
5. ALONSO, D.F., TEJERA, A.M., FARIAS, E.F., BAL DE KIER JOFFE, E. and GOMEZ, D.E., Inhibition of mammary tumor cell adhesion, migration and invasion by the selective synthetic urokinase inhibitor B428. Anticancer Res., 18, 4499-4504 (1998).
6. AON, M.A. and CORTASSA, S., Dynamic biological organization. Fundamentals as applied to cellular systems. Chapman and Hall, London (1997).
7. ARREGUI, C.O., CARBONETTO, S. and MCKERRACHER, L., Characterization of neural adhesion sites: point contacts are the sites of interaction between integrins and cytoskeleton in PC12 cells. J. Neurosci., 14, 6967-6977 (1994).
8. CHOQUET, D., FELSENFELD, D.P. and SHEETZ, M.P., Extracellular matrix rigidity causes strengthening of integrin-cytoskeleton linkages. Cell, 88, 39-48 (1997).
9. COLDITZ, G.A., Epidemiology of breast cancer. Cancer, 71, 1480-1489 (1993).
10. DOMNINA, L.V., IVANOVA, O.Y. and VASILIEV, J.M., Effect of microtubule-specific drugs upon spatial organization of extracellular matrix in fibroblastic cultures. Cell Biol. Int., 19, 743-748 (1995).
11. EDVARDSEN, K., CHEN, W., RUCKLIDGE, G., WALSH, F.S., OBRINK, B. and BOCK, E., Transmembrane neural cell-adhesion molecule (NCAM), but not glycosylphosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metalloproteinases. Proc. nat. Acad. Sci. (Wash.), 90, 11463-11467 (1993).
12. FIDLER, I.J., Cancer metastasis. Brit. med. Bull., 47, 157-177 (1991).
13. HOLMES, F.A., Update: the M.D. Anderson Cancer Center experience with paclitaxel in the management of breast carcinoma. Semin. Oncol., 22, 9-15 (1995).
14. INGBER, D.E., DIKE, L., HANSEN, L., KARP, S., LILEY, H.R., MANIOTIS, A., MCNAMEE, H.R., MOONEY, D., PLOPPER, G., SIMS, J. and WANG, N., Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration and tissue pattern during morphogenesis. Int. Rev. Cytol., 150, 173-224 (1994).
15. JORDAN, A., HADFIELD, J.A., LAWRENCE, N.J. and MCGOWN, A.T., Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med. Res. Rev., 18, 259-296 (1998).
16. JORDAN, M.A., TOSO, R.T., THROWER, D. and WILSON, L., Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc. nat. Acad. Sci. (Wash.), 90, 9552-9556 (1993).
17. LAEMMLI, U., Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature (Lond.), 227, 680-685 (1970).
18. MACDOUGALL, J.R. and KERBEL, R.S., Constitutive production of 92-kDa gelatinase B can be suppressed by alterations in cell shape. Exp. Cell Res., 218, 508-515 (1995).
19. MIGNATTI, P. and RIFKIN, D.B., Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev., 73, 161-195 (1993).
20. MITCHISON, T. and KIRSCHNER, M., Dynamic instability of microtubule growth. Nature (Lond.), 312, 237-242 (1984).
21. PENMAN, S., FULTON, A., CAPCO, D., BENZEV, A., WITTELSBERGER, S. and TSE, C.F., Cytoplasmic and nuclear architecture in cells and tissue: form, functions and mode of assembly. Cold Spring Harb. Symp. Quant. Biol., 46, 1013-1028 (1982).
22. ROWINSKY, E.K. and DONEHOWER, R.C., Antimicrotubule agents. In: V.T. DeVita, S. Hellman and S.A. Rosemberg (eds.), Cancer. Principles and practice of oncology, pp. 467-482, Lippincott-Raven, Philadelphia (1997).
23. SAKSELA, O., Radial caseinolysis in agarose: a simple method for detection of plasminogen activator in the presence of inhibitory substances and serum. Anal. Biochem., 111, 276-282 (1981).
24. SANTIBAÑEZ, J.F., MACCIONI, R.B. and MARTINEZ, J., The secretion of urokinase-like plasminogen activator is inhibited by microtubule-interacting drugs. Cell Biochem. Funct., 13, 217-225 (1995).
25. STEARNS, M.E. and WANG, M., Taxol blocks processes essential for prostate tumor-cell (PC-3 ML) invasion and metastases. Cancer Res., 52, 3776-3781 (1992).
26. TOMASEK, J.J., HALLIDAY, N.L., UPDIKE, D.L., AHERN-MOORE, J.S., VU, T.-K., LIU, R.W. and HOWARD, E.W., Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J. biol. Chem., 278, 7482-7487 (1997).
27. WESTERLUND, A., HUJANEN, E., HOYHTYA, M., PUISTOLA, U. and TURPEENNIEMI-HUJANEN, T., Ovarian cancer cell invasion is inhibited by paclitaxel. Clin. exp. Metastasis, 15, 318-328 (1997).
28. YOSHIDA, D., PIEPMEIER, J.M., BERGENHEIM, T., HENRIKSSON, R. and TERAMOTO, A., Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: in vitro study. Brit. J. Cancer, 77, 21-25 (1998).